checkAd
    Startseite > Aktien > Nanobiotix > Nachrichten
    Nanobiotix Aktie
    6,2150
     
    EUR
    +0,49 %
    +0,0300 EUR
    Letzter Kurs 20:02:02 Tradegate
    6,1600
     
    EUR
    180 STK
    Geldkurs 21:50:00
    6,2750
     
    EUR
    180 STK
    Briefkurs 21:50:00
    ISIN: FR0011341205 · WKN: A1J7EB · SYM: 5NR · Frankreich

    Neueste Nachrichten

    NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
    24.04.24 · globenewswire · Nanobiotix
    NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
    17.04.24 · globenewswire · Nanobiotix
    Voting Rights and Shares Capital of the Company
    10.04.24 · globenewswire · Nanobiotix
    Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
    02.04.24 · globenewswire · Nanobiotix
    Nanobiotix to Present at Upcoming Investor Conferences in March
    06.03.24 · globenewswire · Nanobiotix
    Voting Rights and Shares Capital of the Company
    13.02.24 · globenewswire · Nanobiotix
    Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
    31.01.24 · globenewswire · Nanobiotix
    Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study
    29.01.24 · globenewswire · Nanobiotix
    Voting Rights and Shares Capital of the Company
    11.01.24 · globenewswire · Nanobiotix
    Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets
    26.12.23 · globenewswire · Nanobiotix
    NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update
    13.11.23 · globenewswire · Nanobiotix
    NANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023
    09.11.23 · globenewswire · Nanobiotix